Am J Transplant, Volume 22, Suppl 3 Archives - Page 84 of 190 - ATC Abstracts

2022 American Transplant Congress
Trends of Living Kidney Donor Characteristics in the United States from 2000-2019
N. K. Prabhu¹, V. Villani¹, K. P. Samy¹, D. Sudan¹, K. Ravindra¹, W. Irish²
¹Surgery, Duke University Medical Center, Durham, NC, ²Surgery, East Carolina University, Greenville, NC
*Purpose: While studies have been performed analyzing recipient outcomes after extended criteria living donor kidney transplantation (LDKT), the actual long-term trends of demographic and medical…
2022 American Transplant Congress
Simultaneous Liver and Kidney Transplantation and Gender Disparities in Transplant Access and Outcomes
G. Peschard¹, M. Wang², Y. Al-Hosni³, K. Lentine⁴, S. Chang², T. Alhamad⁵
¹Nephrology, UCSF, San Francisco, CA, ²Division of Public Health Sciences, Department of Surgery, Washington University in St Louis, Saint Louis, MO, ³Division of General Medical Sciences, Washington University in St Louis, Saint Louis, MO, ⁴Saint Louis University Center for Abdominal Transplantation,, Saint Louis University, Saint Louis, MO, ⁵Nephrology, Washington University in St Louis, St Louis, MO
*Purpose: The frequency of simultaneous liver-kidney transplantation (SLKT) has been rising since the implementation of the Model for End-stage Liver Disease (MELD)-liver allocation system in…
2022 American Transplant Congress
Implementation of Robotic Approach for Living Donor Nephrectomy in a High-Volume Laparoscopic Centre
G. Papadakis¹, I. D. Kostakis², A. Kumar¹, P. Kotecha³, P. Gogalniceanu¹, N. Mamode¹, J. Olsburgh¹, B. Challacombe¹, N. Kessaris¹, I. Loukopoulos¹
¹Department of Transplantation, Guy's Hospital, Guy's and St Thomas’ NHS Foundation Trust, London, United Kingdom, ²Department of HPB Surgery and Liver Transplantation, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom, ³Medical School, King's College London, London, United Kingdom
*Purpose: There are not many studies comparing robotic with laparoscopic living donor nephrectomies. Our aim was to report the outcomes of our initial experience with…
2022 American Transplant Congress
Reasons for Kidney Transplant Patients to Have Outpatient Urine Cultures in the First Year Post-Transplant: An Analysis of the USRDS
V. Hemmige¹, E. Akalin², M. Kinkhabwala³
¹Montefiore Medical Center, Bronx, NY, ²Albert Einstein College of Medicine, Montefiore Medical Ctr, Bronx, NY, ³Albert Einstein College of Medicine, Bronx, NY
*Purpose: Urine cultures are frequently sent in the first year after kidney transplant, but the reasons that testing is done post-transplant is not well understood.…
2022 American Transplant Congress
Improved Mortality in COVID-19 Kidney Transplant Recipients Treated with Bamlanivimab
A. Hamiduzzaman, U. Reddy
Nephrology, UC Irvine, Orange, CA
*Purpose: Transplant recipients are particularly vulnerable to catastrophic sequelae of COVID-19. In an early multi-center study of 482 solid organ transplant (SOT) recipients with COVID-19,…
2022 American Transplant Congress
Place Based Risk for Early Rejection in Lung Transplant
W. M. Tsuang¹, X. Wang², J. Curtis³
¹Respiratory Institute, Cleveland Clinic, Cleveland, OH, ²Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ³Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH
*Purpose: Within 5 years after lung transplant (LT), half of recipients have lost 20% or more of lung function. Despite a consistent link between social…
2022 American Transplant Congress
Neighborhood Spatial Accessibility is Not Associated with Days Alive and Out of the Hospital After Kidney Transplant
J. Gunasti
Emory University, Atlanta, GA
*Purpose: Transportation-related barriers to care or to health-promoting resources are often referenced as challenges during the kidney transplant process. However, little is known about the…
2022 American Transplant Congress
Everolimus versus Mycophenolate in Simultaneous Pancreas and Kidney Transplantation: Progression of Diabetic Retinopathy in a Prospective Randomized Trial
B. Hagerf¹, Z. Hladíková¹, M. Zahradnická¹, K. Kesslerová², T. Sosna², P. Girman¹, F. Saudek¹
¹Diabetes Centre, IKEM, Prague, Czech Republic, ²Ophtalmology Clinic, Thomayer Hospital, Prague, Czech Republic
*Purpose: mTOR inhibitors are known for their antiangiogenic effect. We compared the impact of everolimus (E) and mycophenolic acid (MPA) on the course of diabetic…
2022 American Transplant Congress
Evidence for Improved Quality of Life Among Chronic Pancreatitis Patients Undergoing Total Pancreatectomy with Islet Autotransplantation Using EORTC QLQ-C30 and QLQ-PAN 26
M. Coluzzi, B. Naziruddin, G. Saracino, G. Testa, E. Beecherl, N. Onaca
Baylor University Medical Center, Dallas, TX
*Purpose: Total pancreatectomy with islet autotransplantation (TPIAT) is the treatment of choice to preserve endocrine function, alleviate pain, reduce or eliminate chronic narcotic use and…
2022 American Transplant Congress
Is Donor Hepatitis C Virus Infection Status Associated with Early Post-Kidney Transplant Failure in the Era of Direct-Acting Antiviral Medications?
S. Sutcliffe¹, S. Chang¹, D. Stewart², M. Ji³, K. Lentine⁴, G. Gupta⁵, T. Alhamad⁶
¹Washington University School of Medicine, Saint Louis, MO, ²United Network for Organ Sharing, Richmond, VA, ³Washington University in St. Louis School of Medicine, Saint Louis, MO, ⁴Saint Louis University School of Medicine, Saint Louis, MO, ⁵Virginia Commonwealth University School of Medicine, Richmond, VA, ⁶Washington University School of Medicine at St. Louis, Saint Louis, MO
*Purpose: To determine the influence of donor hepatitis C virus (HCV) infection status on early kidney transplant (KT) failure in HCV negative recipients in the…